drugset

drugset / Trial / NCT00751062

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia

NCT00751062 ↗

Phase 3 Completed 267 enrolled Viatris Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

PhXA41 is not inferior to timolol in reducing intra-ocular pressure

Timeline

Start: 1992-11
Primary completion: 1993-12
Completion: 1993-12

Publications

Varma R, Hwang LJ, Grunden JW, Bean GW, Sultan MB. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range. Am J Ophthalmol. 2009 Aug;148(2):221-6. doi: 10.1016/j.ajo.2009.02.035. Epub 2009 May 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Latanoprost	Small molecule	—	Other
Comparator	Timolol	Other / unclassified	—	Other

Indications